3rd ESTRO Forum 2015 planned hospitalization. Full course of radiotherapy can be safely used in older patients but they have a low tolerance to chemotherapy and frequently require dose-reduction; the effect of this chemotherapy is uncertain. Purpose/Objective: The incidence of cancer in the elderly is expected to rise . For example in the USA it is estimated that it will rise by 67% between 2010 to 2030. This is a retrospective analysis audit on radiotherapy to the very elderly defined as patients above 80 years old from Jan 2012 until Dec 2013. We hope to analyse the radiotherapy intent; tumour site analysis and median survival days from the last fraction of radiotherapy. With these understanding, we hope to be able to further better or understanding and plan management for our very elderly who are under our care in future.
Purpose/Objective: The incidence of cancer in the elderly is expected to rise . For example in the USA it is estimated that it will rise by 67% between 2010 to 2030. This is a retrospective analysis audit on radiotherapy to the very elderly defined as patients above 80 years old from Jan 2012 until Dec 2013. We hope to analyse the radiotherapy intent; tumour site analysis and median survival days from the last fraction of radiotherapy. With these understanding, we hope to be able to further better or understanding and plan management for our very elderly who are under our care in future.
Materials and Methods:
We retrospectively collected and analysed the data from our Aria database for all patients above 80 years old on the day they finished treatment from January 2012 until Dec 2013. Results: We treated 1571 patients who were very elderly during these analysed 2 years. 40% of our very elderly were treated with radical intent. Nearly 25% of them were patients treated for Breast Cancer followed by Lung Cancer (20%). There was nearly an equal distribution with 51% of them being male patients. The median days from time of last fraction of radiotherapy to death was 129 days with a maximum of 826 days at time of analysis. Palliative treatments to the very elderly were mainly palliation for bone metastases and lung/ chest palliation. Conclusions: There is a high proportion of the very elderly treated with radical intent with radiotherapy; with Breast and Lung Cancer being the highest malignant cause. There was a fairly equal sex distribution between those treated for radiotherapy in the very elderly. We need to further analyse these data to provide a more meaning insight in order to improve and adequately support our very elderly requiring treatment. 
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